Yes cardiac output will be checked as part of the patient assessment bother before and after. Having said this given the treatment history of the average patient in this trial I doubt we will be able to determine much.
Ann: Expanded Heart Protection Discovery for Zantrene, page-234
-
- There are more pages in this discussion • 153 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.030(1.94%) |
Mkt cap ! $269.1M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.59 | $1.53 | $85.81K | 55.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2026 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 2335 | 1 |
View Market Depth
| Last trade - 13.24pm 01/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |